Next generation immuno-oncology tumor profiling using a rapid, non-invasive, computational biophysics biomarker in early-stage breast cancer

BackgroundImmuno-oncology (IO) therapies targeting the PD-1/PD-L1 axis, such as immune checkpoint inhibitor (ICI) antibodies, have emerged as promising treatments for early-stage breast cancer (ESBC). Despite immunotherapy's clinical significance, the number of benefiting patients remains small...

Cijeli opis

Bibliografski detalji
Glavni autori: Daniel Cook, Matthew Biancalana, Nicole Liadis, Dorys Lopez Ramos, Yuhan Zhang, Snehal Patel, Joseph R. Peterson, John R. Pfeiffer, John A. Cole, Anuja K. Antony
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2023-04-01
Serija:Frontiers in Artificial Intelligence
Teme:
Online pristup:https://www.frontiersin.org/articles/10.3389/frai.2023.1153083/full